TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Alligator Bioscience AB
Closing information (x1000 EUR)
| Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
3,208
|
1,266
|
434 |
| Financial expenses |
58
|
23
|
119 |
| Earnings before taxes |
-17,379
|
-13,859
|
-14,276 |
| EBITDA |
-16,267
|
-12,753
|
-13,228 |
| Total assets |
15,239
|
32,581
|
15,137 |
| Current assets |
11,036
|
29,297
|
10,993 |
| Current liabilities |
5,799
|
4,636
|
3,060 |
| Equity capital |
8,002
|
27,601
|
11,481 |
| - share capital |
7,963
|
8,628
|
2,845 |
| Employees (average) |
50
|
45
|
50 |
Financial ratios
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
52.5%
|
84.7%
|
75.8% |
| Turnover per employee |
64
|
28
|
9 |
| Profit as a percentage of turnover |
-541.7%
|
-1094.7%
|
-3289.4% |
| Return on assets (ROA) |
-113.7%
|
-42.5%
|
-93.5% |
| Current ratio |
190.3%
|
631.9%
|
359.2% |
| Return on equity (ROE) |
-217.2%
|
-50.2%
|
-124.3% |
| Change turnover |
2,045
|
840
|
-1 |
| Change turnover % |
176%
|
197%
|
0% |
| Chg. No. of employees |
5
|
-5
|
-5 |
| Chg. No. of employees % |
11%
|
-10%
|
-9% |
Total value of public sale
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.